Research on Optimal Diagnosis and Treatment of Cardiorenal Syndrome

ConditionsHeart Failure Kidney Diseases Kidney Injury Heart Valve Diseases Dialysis; Complications Coronary Heart Disease

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorNanjing First Hospital, Nanjing Medical University

About this trial

To estimate the characteristics, pathogenesis, risk factors and intervention measures for different stages of heart and kidney diseases, and to optimize the curative effects of different treatment schemes

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

guideline recommended routine treatment

Treatment groups

1,200 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Nanjing First Hospital, Nanjing Medical University

Lead sponsor

Source ClinicalTrials.gov